Jim Simons’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$118K Buy
11,250
+5,850
+108% +$57.1K ﹤0.01% 3005
2025
Q4
$62.1K Buy
+5,400
New +$83.4K ﹤0.01% 3070
2025
Q3
Sell
-12,058
Closed -$198K 3541
2025
Q2
$198K Buy
+12,058
New +$208K ﹤0.01% 3172
2025
Q1
Sell
-40,341
Closed -$1.5M 3500
2024
Q4
$1.5M Sell
40,341
-753
-2% -$28.8K ﹤0.01% 2237
2024
Q3
$1.31M Buy
41,094
+5,990
+17% +$332K ﹤0.01% 2288
2024
Q2
$2.88M Buy
35,104
+30,780
+712% +$3.33M ﹤0.01% 1642
2024
Q1
$626K Sell
4,324
-9,760
-69% -$824K ﹤0.01% 2772
2023
Q4
$1.3M Buy
14,084
+7,290
+107% +$741K ﹤0.01% 2231
2023
Q3
$1.12M Buy
+6,794
New +$883K ﹤0.01% 2221
2022
Q4
Sell
-22,774
Closed -$2.14M 4134
2022
Q3
$2.14M Buy
22,774
+13,620
+149% +$1.94M ﹤0.01% 1969
2022
Q2
$2.04M Buy
9,154
+880
+11% +$295K ﹤0.01% 2175
2022
Q1
$4.55M Sell
8,274
-7,213
-47% -$4.36M 0.01% 1667
2021
Q4
$10.2M Buy
15,487
+13,803
+820% +$10.6M 0.01% 1061
2021
Q3
$1.41M Sell
1,684
-6,050
-78% -$6.14M ﹤0.01% 2351
2021
Q2
$9.82M Buy
+7,734
New +$8.73M 0.01% 1186
2020
Q2
Sell
-23,734
Closed -$8.3M 3464
2020
Q1
$8.3M Sell
23,734
-13,980
-37% -$9.9M 0.01% 1275
2019
Q4
$23.7M Buy
37,714
+27,420
+266% +$13.4M 0.02% 917
2019
Q3
$3.45M Buy
+10,294
New +$3.3M ﹤0.01% 1994

Other funds holding CDLX

Jim Simons's CDLX Position: Q1 2026 in Review

Jim Simons increased its Cardlytics (CDLX) stake by 108% in Q1 2026, buying an estimated $57.1K and bringing the position to 11,250 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #3005.

Jim Simons first reported a position in CDLX in Q3 2019 and has held it in 18 quarters since. The position peaked at $23.7M in Q4 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Jim Simons held 11,250 shares of Cardlytics worth $118K as of Q1 2026.
  • Jim Simons bought 5,850 Cardlytics shares in Q1 2026, an estimated $57.1K.
  • Cardlytics made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #3005 holding.
  • Jim Simons first reported a position in Cardlytics in Q3 2019 and has held it in 18 quarters since.
  • Jim Simons's Cardlytics position peaked at $23.7M in Q4 2019.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.